中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2014年
10期
1382-1387
,共6页
丛恬駪%张铭慧%何海燕%尹永强%吴红%康毅%娄建石
叢恬駪%張銘慧%何海燕%尹永彊%吳紅%康毅%婁建石
총념신%장명혜%하해연%윤영강%오홍%강의%루건석
牛磺酸镁%心律失常%心室肌细胞%钠通道%全细胞膜片钳%胺碘酮
牛磺痠鎂%心律失常%心室肌細胞%鈉通道%全細胞膜片鉗%胺碘酮
우광산미%심률실상%심실기세포%납통도%전세포막편겸%알전동
taurine-magnesium coordination com-pound (TMCC)%arrhythmia%ventricular myocytes%sodium channel%whole-cell patch technique%amioda-rone
目的:观察牛磺酸镁配合物( taurine-magnesium coordi-nation compound,TMCC)对缺氧/复氧损伤所导致的大鼠心肌细胞异常钠通道电流的影响。方法采用Langendorff逆行主动脉灌流酶溶液消化法,急性分离大鼠单个心肌细胞,以缺氧钠外液模拟缺氧15 min后,给予有氧钠外液5 min制备缺氧/复氧模型。应用全细胞膜片钳技术,在电压钳模式下,以胺碘酮为阳性对照药,记录不同浓度TMCC对正常细胞和缺氧复氧模型细胞钠离子通道电流INa的影响。结果与正常对照组INa峰值(56.89±2.07) pA/pF相比,缺氧/复氧使大鼠心室肌细胞INa峰值减小至(35.05±1.52) pA/pF (n=6,P<0.01),I-V曲线上移。 TMCC(100、200、400μmol ·L-1)可使减小的电流呈浓度依赖性增加,分别恢复至(35.78±1.95) pA/pF (n =6,P >0.05)、(41.52±0.86) pA/pF(n=6,P<0.01)、(48.34±0.99) pA/pF(n=6,P<0.01),24.24μmol·L-1胺碘酮使其恢复为(39.44±1.24)pA/pF(n=6,P<0.01)。 TMCC和胺碘酮均能使上移的I-V曲线下移。此外, TMCC和胺碘酮还可恢复因缺氧/复氧右移的失活曲线,使失活减慢,但对激活的影响并不明显。结论 TMCC(200、400μmol·L-1)通过抑制钠通道的失活过程以恢复缺氧/复氧损伤引起的INa峰值减小,使上移的I-V曲线下移,提示该作用可能是TMCC抗缺血性心律失常的机制之一。
目的:觀察牛磺痠鎂配閤物( taurine-magnesium coordi-nation compound,TMCC)對缺氧/複氧損傷所導緻的大鼠心肌細胞異常鈉通道電流的影響。方法採用Langendorff逆行主動脈灌流酶溶液消化法,急性分離大鼠單箇心肌細胞,以缺氧鈉外液模擬缺氧15 min後,給予有氧鈉外液5 min製備缺氧/複氧模型。應用全細胞膜片鉗技術,在電壓鉗模式下,以胺碘酮為暘性對照藥,記錄不同濃度TMCC對正常細胞和缺氧複氧模型細胞鈉離子通道電流INa的影響。結果與正常對照組INa峰值(56.89±2.07) pA/pF相比,缺氧/複氧使大鼠心室肌細胞INa峰值減小至(35.05±1.52) pA/pF (n=6,P<0.01),I-V麯線上移。 TMCC(100、200、400μmol ·L-1)可使減小的電流呈濃度依賴性增加,分彆恢複至(35.78±1.95) pA/pF (n =6,P >0.05)、(41.52±0.86) pA/pF(n=6,P<0.01)、(48.34±0.99) pA/pF(n=6,P<0.01),24.24μmol·L-1胺碘酮使其恢複為(39.44±1.24)pA/pF(n=6,P<0.01)。 TMCC和胺碘酮均能使上移的I-V麯線下移。此外, TMCC和胺碘酮還可恢複因缺氧/複氧右移的失活麯線,使失活減慢,但對激活的影響併不明顯。結論 TMCC(200、400μmol·L-1)通過抑製鈉通道的失活過程以恢複缺氧/複氧損傷引起的INa峰值減小,使上移的I-V麯線下移,提示該作用可能是TMCC抗缺血性心律失常的機製之一。
목적:관찰우광산미배합물( taurine-magnesium coordi-nation compound,TMCC)대결양/복양손상소도치적대서심기세포이상납통도전류적영향。방법채용Langendorff역행주동맥관류매용액소화법,급성분리대서단개심기세포,이결양납외액모의결양15 min후,급여유양납외액5 min제비결양/복양모형。응용전세포막편겸기술,재전압겸모식하,이알전동위양성대조약,기록불동농도TMCC대정상세포화결양복양모형세포납리자통도전류INa적영향。결과여정상대조조INa봉치(56.89±2.07) pA/pF상비,결양/복양사대서심실기세포INa봉치감소지(35.05±1.52) pA/pF (n=6,P<0.01),I-V곡선상이。 TMCC(100、200、400μmol ·L-1)가사감소적전류정농도의뢰성증가,분별회복지(35.78±1.95) pA/pF (n =6,P >0.05)、(41.52±0.86) pA/pF(n=6,P<0.01)、(48.34±0.99) pA/pF(n=6,P<0.01),24.24μmol·L-1알전동사기회복위(39.44±1.24)pA/pF(n=6,P<0.01)。 TMCC화알전동균능사상이적I-V곡선하이。차외, TMCC화알전동환가회복인결양/복양우이적실활곡선,사실활감만,단대격활적영향병불명현。결론 TMCC(200、400μmol·L-1)통과억제납통도적실활과정이회복결양/복양손상인기적INa봉치감소,사상이적I-V곡선하이,제시해작용가능시TMCC항결혈성심률실상적궤제지일。
Aim To investigate the antiarrhythmic mechanism of taurine-magnesium coordination com-pound on abnormal sodium current channel ( INa ) in-duced by hypoxia-reoxygenation in ventricular myocytes of rats. Methods Single ventricular myocytes were i-solated from each rat heart using enzymatic dissociation through Langendorff retrograde aortic perfusion. Whole-cell patch clamp was applied in voltage clamp mode to record INa both in normal ventricular myocytes and single ventricular myocytes of arrhythmia induced by hypoxia-reoxygenation. Results The peak density of INa was changed from ( 56. 89 ± 2. 07 ) pA/pF to (35. 05 ± 1. 52) pA/pF( n=6, P <0. 01 vs control) by hypoxia-reoxygenation with the INa I-V curve shifting upward. TMCC(200, 400 μmol·L-1)was able to re-store the reduction caused by H/R to (35. 78 ± 1. 95) pA/pF, (41. 52 ± 0. 86) pA/pF, (n=6,P <0. 01) and (48. 34 ± 0. 99) pA/pF(n=6,P<0. 01) respec-tively, but not at 100 μmol·L-1(n=6, P>0. 05), in a concentration-dependent manner, while amioda-rone restored it to (39. 44 ± 1. 24) pA/pF (n=6,P<0. 01 ) . Both high concentration of TMCC and amioda-rone could shift the I-V curve downward. In addition, TMCC and amiodarone could restore the INa inactivation curve and slow down its inactivation, whereas the acti-vation curves showed no significant differences among groups. Conclusion TMCC(200,400 μmol·L-1) could restore the H/R induced INa reduction and shift the I-V curve downward by inhibiting steady-state inac-tivation, which is suggested to be one of the mecha-nisms of the antiarrhythmic effects of TMCC in hypoxia-reoxygenation model.